SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: david nordic who wrote (31546)3/29/2005 2:39:59 PM
From: fred hayes  Read Replies (1) | Respond to of 32384
 
Looks like non issue or, more likely, I just don't understand what's going on. Looks to me like Ligand has to pay Royalty Pharma 3 percent of sales of SERMs, but gets only 3 percent of sales of lasofoxifene from PFE? Or where have I missed the boat?

fred hayes